Aberrant Notch pathway can cause drug resistance in ovarian cancer cells, whereas Notch knockdown can increase platinum sensitivity through downregulation of ABCC1 and ABCB1 [121, 122]. This evidence concerns the gene ABCB1 and ovarian cancer.